Free Trial

Spruce Biosciences (SPRB) Short Interest Ratio & Short Volume

→ Executive Order To Wipe Out Your Bank Accounts (From Oasis Gold) (Ad)
Free SPRB Stock Alerts
$0.67
-0.01 (-1.00%)
(As of 12:09 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends

Spruce Biosciences Short Interest Data

Current Short Interest
123,300 shares
Previous Short Interest
215,500 shares
Change Vs. Previous Month
-42.78%
Dollar Volume Sold Short
$98,640.00
Short Interest Ratio
0.1 Days to Cover
Last Record Date
May 15, 2024
Outstanding Shares
41,150,000 shares
Percentage of Shares Shorted
0.30%
Today's Trading Volume
65,184 shares
Average Trading Volume
934,521 shares
Today's Volume Vs. Average
7%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Spruce Biosciences ?

Sign up to receive the latest short interest report for Spruce Biosciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

SPRB Short Interest Over Time

SPRB Days to Cover Over Time

SPRB Percentage of Float Shorted Over Time

Spruce Biosciences Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/2024123,300 shares $98,640.00 -42.8%N/A0.1 $0.80
4/30/2024215,500 shares $152,574.00 +31.4%1.0%0.2 $0.71
4/15/2024164,000 shares $115,734.80 -48.8%0.7%0.1 $0.71
3/31/2024320,400 shares $251,802.36 +69.3%1.5%0.3 $0.79
3/15/2024189,300 shares $152,954.40 +461.7%N/A0.2 $0.81
2/29/202433,700 shares $168,500.00 -33.0%0.2%0.1 $5.00
2/15/202450,300 shares $254,518.00 +17.3%0.3%0.2 $5.06
1/31/202442,900 shares $157,014.00 +117.8%N/A0.2 $3.66
1/15/202419,700 shares $48,856.00 -74.4%N/A0.1 $2.48
12/31/202377,000 shares $225,610.00 +64.5%N/A0.4 $2.93
12/15/202346,800 shares $77,688.00 -10.5%N/A0.3 $1.66
11/30/202352,300 shares $73,220.00 -24.0%N/A0.4 $1.40
11/15/202368,800 shares $79,120.00 +94.4%N/A0.6 $1.15
10/31/202335,400 shares $40,356.00 +49.4%N/A0.4 $1.14
10/15/202323,700 shares $37,683.00 -38.1%N/A0.3 $1.59
9/30/202338,300 shares $86,558.00 -53.4%N/A0.5 $2.26
9/15/202382,100 shares $201,966.00 +203.0%N/A1.1 $2.46
8/31/202327,100 shares $60,975.00 -14.0%N/A0.4 $2.25
8/15/202331,500 shares $68,040.00 -70.4%N/A0.3 $2.16
7/31/2023106,500 shares $239,625.00 +31.5%N/A0.8 $2.25
7/15/202381,000 shares $167,670.00 -16.3%N/A0.6 $2.07
6/30/202396,800 shares $208,120.00 +497.5%N/A0.6 $2.15
6/15/202316,200 shares $38,232.00 -96.6%N/A0.1 $2.36
5/31/2023470,900 shares $1.14 million -59.1%N/A2.9 $2.43
5/15/20231,150,000 shares $2.51 million -12.9%N/A6.6 $2.18
4/30/20231,320,000 shares $2.72 million -6.4%N/A7 $2.06
4/15/20231,410,000 shares $2.74 million +16.5%N/A6.5 $1.94
3/31/20231,210,000 shares $2.67 million +15.2%N/A2.6 $2.21
3/15/20231,050,000 shares $2.37 million -3.7%N/A0.7 $2.26
2/28/20231,090,000 shares $2.47 million +30.0%N/A0.7 $2.27
2/15/2023838,400 shares $2.29 million +1.6%13.6%0.6 $2.73
1/31/2023825,400 shares $2.43 million -31.8%6.8%0.6 $2.95
1/15/20231,210,000 shares $3.34 million +77.1%10.0%0.9 $2.76
12/30/2022683,100 shares $749,633.94 +16.1%5.6%0.5 $1.10
12/15/2022588,600 shares $588,600.00 +17.5%4.9%9.7 $1.00
11/30/2022500,900 shares $550,990.00 +52.3%4.1%9.3 $1.10
11/15/2022328,900 shares $345,345.00 +23.2%2.7%6.4 $1.05
10/31/2022267,000 shares $296,370.00 +211.9%2.2%7.9 $1.11
10/15/202285,600 shares $97,584.00 +40.1%0.7%2.6 $1.14
9/30/202261,100 shares $83,707.00 -19.5%0.5%2.2 $1.37
Trump convicted... now what? (Ad)

Unexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. But while the Left celebrates his conviction... and the Right rallies around him... the average American is not prepared for what happens next.

Which is why it's so important to access this presentation while it's still available online.
9/15/202275,900 shares $132,825.00 +22.0%0.6%1.7 $1.75
8/31/202262,200 shares $136,218.00 -13.6%0.5%1 $2.19
8/15/202272,000 shares $154,800.00 -31.8%0.6%0.5 $2.15
7/31/2022105,600 shares $195,360.00 +16.3%0.9%0.7 $1.85
7/15/202290,800 shares $171,612.00 -26.7%0.8%0.5 $1.89
6/30/2022123,900 shares $215,586.00 -71.2%1.0%0.7 $1.74
6/15/2022429,700 shares $687,520.00 +2.8%3.6%2.3 $1.60
5/31/2022417,900 shares $651,924.00 +8.2%3.5%2.2 $1.56
5/15/2022386,200 shares $525,232.00 -0.5%3.2%3.1 $1.36
4/30/2022388,300 shares $683,408.00 +2.5%3.5%2.8 $1.76
4/15/2022378,700 shares $802,844.00 +21.3%3.4%2.2 $2.12
3/31/2022312,100 shares $627,321.00 -5.1%3.5%1 $2.01
3/15/2022328,700 shares $608,095.00 -17.8%4.6%0.2 $1.85
2/28/2022399,900 shares $907,773.00 -4.4%5.6%0.1 $2.27
2/15/2022418,300 shares $962,090.00 -7.6%5.9%0.1 $2.30
1/31/2022452,600 shares $1.15 million -10.5%6.4%0.1 $2.54
1/15/2022505,400 shares $1.73 million -58.2%6.4%0.1 $3.43
12/31/20211,210,000 shares $5.40 million +78.7%17.1%0.3 $4.46
12/15/2021677,300 shares $1.69 million +28.4%9.6%0.2 $2.50
11/30/2021527,700 shares $1.36 million +10.8%7.5%3.9 $2.58
11/15/2021476,200 shares $2.09 million -0.7%6.8%4.4 $4.39
10/29/2021479,500 shares $2.28 million +2.0%6.8%7.7 $4.76
10/15/2021470,100 shares $2.11 million -3.0%6.0%9.6 $4.48
9/30/2021484,700 shares $2.91 million -10.5%6.2%11.2 $6.01
9/15/2021541,500 shares $3.91 million +1.3%7.0%10.3 $7.22
8/31/2021534,700 shares $4.10 million +0.6%6.9%8.7 $7.67
8/13/2021531,500 shares $4.08 million +9.3%6.9%8.9 $7.67
7/30/2021486,400 shares $4.48 million -1.6%6.3%6.9 $9.21
7/15/2021494,100 shares $4.91 million -3.1%6.4%6.1 $9.94
6/30/2021510,100 shares $5.72 million +5.6%6.6%6.4 $11.21
6/15/2021483,300 shares $5.62 million +6.5%6.2%6.8 $11.63
5/28/2021454,000 shares $6.42 million -1.9%5.9%6.4 $14.13
5/14/2021462,800 shares $6.76 million +3.2%6.4%6.7 $14.60
4/30/2021448,500 shares $7.83 million -4.6%6.2%7.9 $17.46
4/15/2021470,100 shares $7.46 million +9.9%6.5%9.6 $15.87
3/31/2021427,800 shares $6.51 million +9.1%5.9%9.5 $15.21
3/15/2021392,300 shares $10.12 million +0.7%5.4%5.9 $25.79
2/26/2021389,600 shares $8.26 million +3.3%5.4%6.2 $21.21
2/12/2021377,300 shares $8.05 million -1.4%5.2%5.8 $21.34
1/29/2021382,500 shares $7.68 million -3.8%6.2%5 $20.08
1/15/2021397,400 shares $9.41 million No Change6.4%4.7 $23.69

SPRB Short Interest - Frequently Asked Questions

What is Spruce Biosciences' current short interest?

Short interest is the volume of Spruce Biosciences shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 123,300 shares of SPRB short. Learn More on Spruce Biosciences' current short interest.

Is Spruce Biosciences' short interest increasing or decreasing?

Spruce Biosciences saw a drop in short interest during the month of May. As of May 15th, there was short interest totaling 123,300 shares, a drop of 42.8% from the previous total of 215,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Spruce Biosciences' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Spruce Biosciences: Eagle Pharmaceuticals, Inc. (9.97%), Adicet Bio, Inc. (8.45%), Immunic, Inc. (3.13%), Coya Therapeutics, Inc. (1.37%), DiaMedica Therapeutics Inc. (0.34%), Vistagen Therapeutics, Inc. (4.36%), PDS Biotechnology Co. (18.68%), Cellectar Biosciences, Inc. (6.54%), Tiziana Life Sciences Ltd (0.16%), Allakos Inc. (5.74%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

What does it mean to sell short Spruce Biosciences stock?

Short selling SPRB is an investing strategy that aims to generate trading profit from Spruce Biosciences as its price is falling. SPRB shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Spruce Biosciences?

A short squeeze for Spruce Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SPRB, which in turn drives the price of the stock up even further.

How often is Spruce Biosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SPRB, twice per month. The most recent reporting period available is May, 15 2024.



More Short Interest Resources from MarketBeat

Related Companies:
Short Interest Tools:
This page (NASDAQ:SPRB) was last updated on 6/10/2024 by MarketBeat.com Staff

From Our Partners
AI's Next Magnificent Seven
The Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.
The Oxford Club | Sponsored
Elon Musk’s Final Masterpiece: “X-9840”
The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Ju...
Paradigm Press | Sponsored
Who are Nvidia’s Silent Partners?
Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.
Weiss Ratings | Sponsored
[PDF Inside] Crypto's $1 Trillion 60-Day Boom + New 2024 Profit Strategy
The crypto industry is exploding and Chris Munch just released a new PDF detailing how you can potentially pro...
DeFi Distribution | Sponsored
Trump convicted... now what?
Unexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...
Stansberry Research | Sponsored
It's time to ween off Chinese lithium!
As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...
Smallcaps Daily | Sponsored
Top 5 Tech Stocks to Buy for 2024
The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...
Daily Market Alerts | Sponsored
Top 5 AI Stocks to Buy for 2024
The electric vehicle boom is accelerating – and fast.
Market Moving Trends | Sponsored